Rocket Doctor Approved as In-Network Provider for New York Medicaid, Expands Partnership with EngageWell to Enhance Care
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) Announces Rocket Doctor’s Approval as an In-Network Provider for New York Medicaid Strengthening Access to Virtual Healthcare Across the State and Collaboration with EngageWell. Approved as an in-network provider for New York Medicaid, covering 6.9 million individuals (35% of the state’s population) Expands Rocket Doctor’s […]
Treatment.com AI and Rocket Doctor CEO’s meet for a fireside chat to discuss the recently announced acquisition and the future of AI in healthcare
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, February 20, 2025 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to advise that further to its announcement that it has entered into a Definitive Share Purchase Agreement dated February […]
Rocket Doctor Signs Agreement with California Managed Care Plan
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES Rocket Doctor partners with new Managed Care Plan serving ~450,000 California Medicaid members Future anticipated additional ARR of ~US$1.2 million Mission to break down barriers to healthcare access Reducing unnecessary ER visits, reducing wait times, timely specialist referrals […]
Treatment.com AI Enters into a Definitive Agreement to Acquire Rocket Doctor Inc. a Rapidly Growing Digital Health Company Empowering MDs to Provide Comprehensive Care to Patients Across the United States and Canada
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES Addition of ~[C$1.9] million unaudited ARR SaaS revenues Total Billable Value of Services increased to ~ C$7.1 million, up from C$4.3 million in 2023 Growing Network of over 300 doctors currently supporting up to 20 specialties (inc. GP […]
Treatment.com AI Enters Into a Binding Letter of Intent to Acquire Alea Health Holdings Limited adding an AI Powered Voice Agent and Mental Health to its Platform
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES Strategic Expansion with Proposed Acquisition of Alea Health Holdings Limited, a UAE based AI company Proprietary Voice Agent using Conversational AI for onboarding and triaging patients Extended geographic reach – entry into the Middle East Healthcare market Advancing […]
Treatment.com AI Inc. Announces Automatic Conversion of Special Warrants
Treatment.com special warrants to convert Dec. 27 Dr. Essam Hamza reports Treatment.com AI Inc. has filed a prospectus supplement dated Dec. 20, 2024, to its short form base shelf prospectus dated June 24, 2024, to qualify the distribution of securities underlying 2,138,766 special warrants issued by the company on Oct. 25, 2024. The prospectus supplement […]
Treatment.com AI Announces Release of New Medical Education Suite (MES) and Update on the AI Assessment Symposium 1st November, 2024
Treatment.com AI announces expanded and updated MES new releases Lead commercial participant at Global/North American Symposium on AI Assessment in Medical Education Further enhancements and solutions set for H2 2024 VANCOUVER, British Columbia, November 4th, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce the launch of its […]
Treatment.com Ai Inc. Closes Over-subscribed Non- Brokered Private Placement Of $1,954,074
Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States. Vancouver, British Columbia, October 25, 2024 – Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) is pleased to announce that, further […]
Treatment.com AI Announces Non-Brokered Private Placement of up to $1,750,000 of Special Warrants
Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States. Vancouver, British Columbia, October 4, 2024 – Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) is pleased to announce that it […]
Treatment.com AI to Present at the 2024 Cantech Letter Conference in Toronto,ON
Treatment.com AI CEO, Dr. Essam Hamza, is to present live at 11:00 AM ET on Wednesday, October 9, 2024. VANCOUVER, British Columbia (Newsfile Corp. – October 1, 2024) – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”), a healthcare tech company focused on transforming patient care with AI-driven Clinical insights, is pleased to […]